Riken Vitamin Co., Ltd.

TSE:4526 Stock Report

Market Cap: JP¥73.1b

Riken Vitamin Past Earnings Performance

Past criteria checks 4/6

Riken Vitamin has been growing earnings at an average annual rate of 35.4%, while the Food industry saw earnings growing at 8.4% annually. Revenues have been growing at an average rate of 2.9% per year. Riken Vitamin's return on equity is 10.7%, and it has net margins of 8.9%.

Key information

35.4%

Earnings growth rate

35.6%

EPS growth rate

Food Industry Growth4.1%
Revenue growth rate2.9%
Return on equity10.7%
Net Margin8.9%
Next Earnings Update14 Feb 2025

Recent past performance updates

Riken Vitamin's (TSE:4526) Earnings Are Of Questionable Quality

Nov 21
Riken Vitamin's (TSE:4526) Earnings Are Of Questionable Quality

Recent updates

Riken Vitamin's (TSE:4526) Earnings Are Of Questionable Quality

Nov 21
Riken Vitamin's (TSE:4526) Earnings Are Of Questionable Quality

Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50

Aug 28
Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50

Riken Vitamin (TSE:4526) Has Announced A Dividend Of ¥40.50

Aug 13
Riken Vitamin (TSE:4526) Has Announced A Dividend Of ¥40.50

Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50

Jul 26
Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50

Riken Vitamin's (TSE:4526) Dividend Will Be ¥40.50

Jul 11
Riken Vitamin's (TSE:4526) Dividend Will Be ¥40.50

Riken Vitamin's (TSE:4526) Promising Earnings May Rest On Soft Foundations

May 21
Riken Vitamin's (TSE:4526) Promising Earnings May Rest On Soft Foundations

Riken Vitamin (TSE:4526) Has Announced That It Will Be Increasing Its Dividend To ¥44.50

Mar 15
Riken Vitamin (TSE:4526) Has Announced That It Will Be Increasing Its Dividend To ¥44.50

Riken Vitamin (TSE:4526) Is Increasing Its Dividend To ¥44.50

Mar 01
Riken Vitamin (TSE:4526) Is Increasing Its Dividend To ¥44.50

Revenue & Expenses Breakdown

How Riken Vitamin makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSE:4526 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2494,0208,34318,1113,315
30 Jun 2492,7528,54921,0990
31 Mar 2491,4848,75516,9413,315
31 Dec 2390,5057,60316,5233,220
30 Sep 2389,7326,93516,5083,220
30 Jun 2389,3706,64916,6013,220
31 Mar 2388,7506,41416,6703,220
31 Dec 2286,9486,76116,7242,992
30 Sep 2284,2597,56616,4142,992
30 Jun 2281,3007,74715,9472,992
31 Mar 2279,23121,58216,5152,992
31 Dec 2178,20320,09116,5523,094
30 Sep 2178,36518,40217,2723,094
30 Jun 2178,76515,90517,8263,094
31 Mar 2177,722-1,61817,3123,094
31 Dec 2078,977-5,37917,5593,089
30 Sep 2079,403-6,31217,3313,089
30 Jun 2080,938-9,33717,3423,089
31 Mar 2082,974-8,93317,6623,089
31 Dec 1984,889-5,68718,1102,872
30 Sep 1986,754-4,34217,9692,872
30 Jun 1987,40936218,2082,872
31 Mar 1989,0242,62318,1682,872
31 Dec 1890,2544,84518,2672,895
30 Sep 1889,9884,28418,3232,895
30 Jun 1890,1544,21017,8682,895
31 Mar 1889,5154,80017,6952,895
31 Dec 1789,4743,69717,3532,791
30 Sep 1788,4724,80617,2802,791
30 Jun 1787,4444,16917,3312,791
31 Mar 1787,1814,08917,2642,791
31 Dec 1687,5234,21117,3302,633
30 Sep 1687,0303,49817,2442,633
30 Jun 1688,3654,43317,0752,633
31 Mar 1688,0724,10717,0212,633
31 Dec 1587,5744,01716,6762,843
30 Sep 1587,5594,12016,7872,843
30 Jun 1586,4643,95616,8102,843
31 Mar 1585,6033,79516,8102,843
31 Dec 1485,1763,51416,9212,943
30 Sep 1485,4583,52616,8862,943
30 Jun 1485,3263,40916,9102,943
31 Mar 1485,4193,59016,7212,943
31 Dec 1383,2563,40316,4692,809

Quality Earnings: 4526 has high quality earnings.

Growing Profit Margin: 4526's current net profit margins (8.9%) are higher than last year (7.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4526 has become profitable over the past 5 years, growing earnings by 35.4% per year.

Accelerating Growth: 4526's earnings growth over the past year (20.3%) is below its 5-year average (35.4% per year).

Earnings vs Industry: 4526 earnings growth over the past year (20.3%) exceeded the Food industry 19.5%.


Return on Equity

High ROE: 4526's Return on Equity (10.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:19
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Riken Vitamin Co., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCompany Forecast
null nullDaiwa Securities Co. Ltd.
Yumiko KaiIchiyoshi Research Institute Inc.